Categories October Surprise 2024 Phase 4 Data Support Effectiveness of Deutetrabenazine in … Post author By Post date November 29, 2025 Real-world data from Teva Pharmaceuticalsā IMPACT-TD Registry showed that deutetrabenazine and its extended-release formulation led to significant reductions of involuntary movements and improved quality of life for adults with tardive dyskinesia.